- Home
- KLIC vs XENE Comparison
KLIC vs XENE Comparison
Compare KLIC & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- XENE
- Stock Information
- Founded
- KLIC 1951
- XENE 1996
- Country
- KLIC United States
- XENE Canada
- Employees
- KLIC N/A
- XENE N/A
- Industry
- KLIC Semiconductors
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- XENE Health Care
- Exchange
- KLIC Nasdaq
- XENE Nasdaq
- Market Cap
- KLIC 2.4B
- XENE 2.5B
- IPO Year
- KLIC N/A
- XENE 2014
- Fundamental
- Price
- KLIC $29.10
- XENE $35.11
- Analyst Decision
- KLIC Strong Buy
- XENE Strong Buy
- Analyst Count
- KLIC 5
- XENE 8
- Target Price
- KLIC $52.00
- XENE $56.38
- AVG Volume (30 Days)
- KLIC 784.0K
- XENE 870.9K
- Earning Date
- KLIC 04-30-2025
- XENE 05-08-2025
- Dividend Yield
- KLIC 2.82%
- XENE N/A
- EPS Growth
- KLIC N/A
- XENE N/A
- EPS
- KLIC 0.06
- XENE N/A
- Revenue
- KLIC $701,167,000.00
- XENE N/A
- Revenue This Year
- KLIC $7.12
- XENE N/A
- Revenue Next Year
- KLIC $19.40
- XENE $1,553.36
- P/E Ratio
- KLIC $466.06
- XENE N/A
- Revenue Growth
- KLIC N/A
- XENE N/A
- 52 Week Low
- KLIC $26.63
- XENE $26.74
- 52 Week High
- KLIC $53.71
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- KLIC 36.27
- XENE 55.88
- Support Level
- KLIC $28.77
- XENE $32.35
- Resistance Level
- KLIC $30.92
- XENE $34.08
- Average True Range (ATR)
- KLIC 2.21
- XENE 2.43
- MACD
- KLIC 0.06
- XENE 0.57
- Stochastic Oscillator
- KLIC 32.89
- XENE 96.54
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.